Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
University of Alberta
$70,000.00
Appetite and Metabolism in Magel2-null Mice: A Model for Prader Willi Syndrome
FY 2009-10
Summary
People with Prader-Willi syndrome (PWS) have significant disturbances in metabolic function which cause insatiable hunger and often lead to morbid obesity very early in life. Complications of obesity, including cardiovascular disease and type II diabetes, are major sources of morbidity and mortality in PWS. Understanding the underlying physiology of this disturbed metabolism in PWS has been complicated by the fact that several genes are lost in this syndrome, and the contribution of each gene is unknown. To address this fact, researchers have been creating and studying animal models that are missing only single PWS genes, allowing specific gene-related changes to be identified and further studied. One of these genes is called Magel2, and the Wevrick Laboratory has a mouse model missing this gene, referred to as Magel2-null. Magel2-null mice are a valuable model for PWS, as they display some of the changes seen in PWS, notably an early failure to thrive, followed by excessive weight gain and excess adiposity ad adults. Because this gene is only expressed in the brain, Magel2-null mice provide an opportunity to further understand neural control of appetite and metabolism in PWS, as well as in other forms of morbid obesity. We are further investigating both acute and long term alterations in energy metabolism in the Magel2-null mouse, including their response to energy signals such as leptin. The results of specific diets and dietary challenges will be compared between Magel2-null and control mice. Direct neuronal properties in energy centers of the hypothalamus will be measured using techniques in electrophysiology, and compared between Magel2-null and control mice to provide an understanding of changes that occur in this model. This understanding may contribute to the development of specific therapies to help those with PWS, and those with other forms of obesity with similar changes, have a better quality of life.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
206178
Name
Mercer Rebecca E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Appetite and Metabolism in Magel2-null Mice: A Model for Prader Willi Syndrome
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Diet; Electrophysiology; Genetics; Hypothalamus; Immunohistochemistry; Metabolism; Obesity; Pharmacology; Prader-Willi Syndrome; Rt-Pcr
Abstract
People with Prader-Willi syndrome (PWS) have significant disturbances in metabolic function which cause insatiable hunger and often lead to morbid obesity very early in life. Complications of obesity, including cardiovascular disease and type II diabetes, are major sources of morbidity and mortality in PWS. Understanding the underlying physiology of this disturbed metabolism in PWS has been complicated by the fact that several genes are lost in this syndrome, and the contribution of each gene is unknown. To address this fact, researchers have been creating and studying animal models that are missing only single PWS genes, allowing specific gene-related changes to be identified and further studied. One of these genes is called Magel2, and the Wevrick Laboratory has a mouse model missing this gene, referred to as Magel2-null. Magel2-null mice are a valuable model for PWS, as they display some of the changes seen in PWS, notably an early failure to thrive, followed by excessive weight gain and excess adiposity ad adults. Because this gene is only expressed in the brain, Magel2-null mice provide an opportunity to further understand neural control of appetite and metabolism in PWS, as well as in other forms of morbid obesity. We are further investigating both acute and long term alterations in energy metabolism in the Magel2-null mouse, including their response to energy signals such as leptin. The results of specific diets and dietary challenges will be compared between Magel2-null and control mice. Direct neuronal properties in energy centers of the hypothalamus will be measured using techniques in electrophysiology, and compared between Magel2-null and control mice to provide an understanding of changes that occur in this model. This understanding may contribute to the development of specific therapies to help those with PWS, and those with other forms of obesity with similar changes, have a better quality of life.
Competitiondate
200910
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Mercer, Rebecca E
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~